Scientist, Biology at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Ph.D. in immunology, molecular/cell biology, biochemistry, or a related discipline (PhD level is strongly preferred) and 2 years of postdoctoral experience is strongly preferred OR Master’s degree with 8–10 years of relevant industry experience
  • Extensive expertise in T cell biology and cellular immunology
  • Proven hands-on experience in T cell engineering, including CRISPR and other gene-editing platforms, as well as TCR and CAR design
  • Experience with in vivo LNP delivery strongly preferred
  • Familiarity with preclinical in vivo models of inflammation or autoimmunity is desirable
  • Working knowledge of R or Python for data analysis is a plus
  • Strong publication record with first-author papers in high-impact journals
  • Excellent communication, collaboration, and organizational skills

Responsibilities

  • Design and conduct in vitro and in vivo studies to advance understanding of T cell biology and antigen responsiveness
  • Develop and assess innovative therapeutic approaches, including engineered T cells, cellular therapies, and in vivo targeting strategies
  • Apply CRISPR and other gene-editing technologies to engineer T cells for research and therapeutic purposes
  • Establish and refine preclinical models to evaluate immune modulation and therapeutic efficacy
  • Collaborate with multidisciplinary teams across immunology, biochemistry, medicinal chemistry, and bioinformatics
  • Communicate findings to internal teams and leadership; contribute to publications, patents, and regulatory documentation
  • Stay abreast of emerging technologies and scientific literature to drive innovation

Skills

Key technologies and capabilities for this role

T cell biologyin vivo modelingT cell engineeringin vitro studiesin vivo studiesimmune regulationantigen responsiveness

Questions & Answers

Common questions about this position

What qualifications are required for the Scientist, Biology position?

A Ph.D. in immunology, molecular/cell biology, biochemistry, or a related discipline with 2 years of postdoctoral experience is strongly preferred, or a Master’s degree with 8–10 years of relevant industry experience. Extensive expertise in T cell biology and cellular immunology is required.

Is this a remote position or does it require working in an office?

This is a laboratory-based role located in Foster City, CA, requiring on-site work.

What key skills and expertise are needed for this role?

The role requires expertise in T cell biology, in vivo modeling, T cell engineering, CRISPR and gene-editing technologies, and experience designing in vitro and in vivo studies.

What is the work environment like at Gilead Sciences?

The role is part of a collaborative research environment in the Inflammation Biology team, involving multidisciplinary collaboration across immunology, biochemistry, medicinal chemistry, and bioinformatics.

What makes a strong candidate for this Scientist position?

Strong candidates will have a Ph.D. with postdoctoral experience in immunology or related fields, extensive T cell biology expertise, and hands-on experience with in vivo models, gene-editing, and innovative therapeutic development.

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI